As employers, consumers and government officials grow increasingly frustrated by upwardly spiraling drug costs, pressure is building against a handful of powerful companies that have prospered for years as middlemen between drug manufacturers and those who pay for medicines.
The companies, called pharmacy benefit managers, administer drug plans for some 200 million Americans and play a critical role in determining which drugs people take for different ailments.
